2 Biotech Stocks That Could Have Tripled Your Money This Year
One has a better chance to keep climbing than the other does.
Replimune Group, Inc.
REPL
REPL
$43.23
-$2.34
-5.1%
Price as of January 15, 2021, 9:00 p.m. EST
View Interactive REPL Charts
Replimune Group, Inc.
Interactive Chart
News & Analysis: Replimune Group, Inc.
2 Top Biotech Stocks From the IPO Class of 2018 to Buy Now
Compelling clinical trial results so far make these biotech stocks worth more attention than they've received so far.
Why Replimune Stock Is Soaring Today
The company plans to present encouraging early-stage clinical data at a major conference next month.
